LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 2,441 pages found matching data breach- Ketek Approval Still Haunting FDA Part II
Jul-12-07 Rockville MD: The doctor involved in the Ketek trial has been charged for her actions and sentenced to 57 months in prison after pleading guilty to one count of mail fraud. She enrolled 400 patients into the study, more than any other doctor. At the rate Sanofi-Aventis offered per patient, $400, that was a lot of extra income. Her illegal actions alleged... - Ketek Approval Still Haunting FDA
Jul-10-07 Rockville MD: The approval of Ketek still haunts the U.S. Food and Drug Administration (FDA), three years after it was first introduced on the market and six years after Sanofi-Aventis first applied for approval to market the antibiotic. Ketek is one of three drugs, the other two being Vioxx and Avandia, that came under scrutiny after being approved bec... - Big Pharma Implant For-Profit Industry Not Deserving of Preemption Protection Part I
Jul-9-07 Washington, DC: In addition to the question of how many soldiers will be dead or injured by the time self-proclaimed "war President" George Bush leaves office, Americans need to ask themselves how many citizens will be dead or injured as a result of an FDA controlled by the industry most credited with funding his move to the White House. Last year, the... - Gerald Metals Asarco Breach of Contract Settlement
Dallas, TX: (Jul-05-07) Asarco LLC, a copper producer, filed a lawsuit against Gerald Metals, a metals trading company, in 2006 over a contracts dispute between the two companies. The suit charged breach of contract and fraud. In its complaint, Asarco claimed Gerald Metals owed it $7.1 million from various agreements. The bulk of that money, more than $5 m... - Scientists Demand Action on Avandia: New FDA Panels Formed
Jul-8-07 Cleveland, OH: At the recent American Diabetes Association's annual meeting in Chicago, Dr. Steven Nissen, chief of cardiology at the Cleveland Clinic, said early data on links between Avandia and cardiac events were ignored by the drug's maker, Glaxo Smith Klein, including findings presented at the FDA advisory meeting prior to Avandia's approval. "... - Clark & Post Architects City Hall Building Costs Settlement
Elyria, OH: (Jul-05-07) The city of Elyria filed a breach of contract lawsuit against Clark & Post Architects of Lorain in May 2005, claiming $2.5 million for excessive costs incurred during the building of the New City Hall. The city's lawsuit claimed the architects failed to evaluate conditions at the 139-year-old City Hall and misled the city into incor... - AMO Complete MoisturePlus: Link to Acanthamoeba Keratitis Confirmed
Jul-6-07 Jacksonville, FL: According to a just-released report, ongoing investigations have confirmed a strong link between AMO Complete MoisturePlus Multi-Purpose lens Solution , and increased risk for the development of Acanthamoeba keratitis (AK). In the July issue of the American Journal of Ophthalmology (AJO), researchers spoke of a "strong association" be... - Avandia: Strong Link to Heart Failure
Jul-5-07 Coleman, TX Gene Canales is a Vietnam Veteran and a diabetic. Three years ago, his doctor at the VA hospital prescribed Avandia, but now Canales is more worried about his heart than diabetes. "They started me with 8mg but I started to get chest pains," says Canales. "I had a stress test and the doctor told me that I had an irregular heartbeat so he r... - Largest Verdict for Fraud ever rendered for Deception related to E-Z-GO Golf Cars
Jul-5-07 Stephen Jamieson, a partner in the law firm Solomon, Saltsman & Jamieson based in Los Angeles, California, in association with Tom Ward of the Lancaster based law firm Michelizzi, Schwabacher, Ward & Collins, obtained a Judgment for Fraud against E-Z-Go division of Textron, Inc. also known as TEXTRON INC this month. TEXTRON INC., a multinational defense con... - Zyprexa: Courts Can Help
Jul-5-07 Brooklyn, NY Somewhere on YouTube is a video clip featuring Shahram Ahari, a former account executive at Eli Lilly, claiming that he was told to play down the adverse side effects of Zyprexa , which he used to sell on behalf of the company. A spokesperson from Eli Lilly & Co. counters that Ahari is a paid witness in a case against a New Hampshire... - Zyprexa: Rampant Off-Label Use
Jul-3-07 Brooklyn, NY Yet another example of an anti-psychotic drug allegedly presenting links to diabetes and weight gain is Zyprexa , manufactured by Eli Lilly & Co. and prescribed for the treatment of schizophrenia and bipolar mania. However, patients may be getting more than they bargained for, with the possibility of hyperglycemia, diabetes, blood su... - How Class Action Members Receive Notice
Jul-2-07 New York, NY: LawyersandSettlements.com asked notice expert Todd Hilsee how people involved in a class action lawsuit (also called plaintiffs or members) are found and notified of settlements -- and how to ensure they get the right benefits. "It is a very careful process: lawyers must notify members of their legal rights and they also need to notify the... - Problems Associated with Ketek Extend Beyond Liver Problems
Jul-2-07 Washington, DC: The side effect most people think of when they hear the name Ketek is liver failure. However, at least one person has had a different, life-threatening reaction to Ketek; now patients are investigating the possibility of filing lawsuits against the manufacturer Sanofi-Aventis for serious side effects like toxic epidermal necrolysis (TEN)... - GLG Partners Hedge Fund Fraud Fine
Boston, MA: (Jun-26-07) The US Securities and Exchange Commission brought charges against hedge fund GLG Partners, alleging that a probe revealed that the company had earned $2.2 million in illegal profits. Regulators said the firm engaged in manipulative short-selling that helped earn it $2.2 million in illegal profit between July 2003 and July 2005. The... - Parker Chapin Flattau & Klimpl, LLP Breach of Fiduciary Duties Settlement
New York, NY: (Jun-26-07) Parker Chapin Flattau & Klimpl, LLP, a former prominent Manhattan law firm, was charged with committing a "wanton and reckless or malicious act" by a New York City jury, who ruled after a six-day trial. The suit alleged that Henry I. Rothman, Esq., a Parker Chapin partner who now heads the Israeli Practice Team at the Manhattan... - Jeffrey Bradley and Robert Martin CMS Employee Fraud Settlement
Washington, DC: (Jun-26-07) The Commodity Futures Trading Commission booked charges against two former CMS Energy Corp. employees, Jeffrey Bradley and Robert Martin, alleging that they tried to manipulate natural gas markets in 2001 and 2002. The Commodity Futures Trading Commission claimed that former CMS natural gas traders reported false information abo... - Complete MoisturePlus: Profits Fall for AMO Since Recall
Jun-27-07 Santa Ana, CA It has been a little over a month since the AMO Complete MoisturePlus lens solution recall -- and beyond the damage done to people's eyes, is the fallout on the balance sheet. It is being reported that Advanced Medical Optics will lose anywhere from U.S. $57 million to $69 million this year alone, based on the anticipated lost sales of $... - Intergel Scandal: A "Dangerous Precedent" at FDA?
Jun-24-07 Washington, DC In the wake of the Gynecare Intergel recall, many critics are questioning why the Food and Drug Administration (FDA) ever approved Intergel for medical use. Could it be, as some suggest, that the FDA is playing politics to its drug-company funders? Intergel: Initially "Not Approvable" Initially (2000) the FDA rejected Intergel as "no... - Part 1: Avandia and the FDA: The Bottom Line
Jun-19-07 Washington, DC The FDA has come under vocal criticism in the last three weeks over its handling of Avandia , the widely-prescribed GlaxoSmithKline diabetes drug. The FDA's supporters and its critics are still offering their views of what happened, what should have happened, and what should happen in the future. As regular readers will know, Avandia wa... - Zelnorm linked to heart attack and stroke in Canada
The withdrawal of Zelnorm from the market may be bad news to patients with Irritable Bowel Syndrome (IBS) but taking the drug may prove to be more dangerous than not. Health Canada has directed Novartis to stop Canadian sales and marketing of the prescriptive medication Zelnorm (tegaserod hydrogenmaleate) after a recent study of clinical trial data in the...